Kathmere Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Kathmere Capital Management's LLY Position: Q1 2026 in Review
Kathmere Capital Management increased its Eli Lilly (LLY) stake by 23% in Q1 2026, buying an estimated $835K and bringing the position to 4,463 shares worth $4.1M. The position accounts for 0.25% of the portfolio, ranked #75.
Kathmere Capital Management first reported a position in LLY in Q1 2022 and has held it in 17 quarters since. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Kathmere Capital Management held 4,463 shares of Eli Lilly worth $4.1M as of Q1 2026.
- Kathmere Capital Management bought 824 Eli Lilly shares in Q1 2026, an estimated $835K.
- Eli Lilly made up 0.25% of Kathmere Capital Management's portfolio in Q1 2026, its #75 holding.
- Kathmere Capital Management first reported a position in Eli Lilly in Q1 2022 and has held it in 17 quarters since.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Kathmere Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.